Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
| venolymphatic_malformation [2015/07/04 03:08] – admin | venolymphatic_malformation [2025/04/18 20:40] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Venolymphatic Malformation ====== | ||
| + | * Previously known as Lymphangioma | ||
| + | * Lesions with more venous component have more difficult course. | ||
| + | * Ultrasound localization | ||
| + | * Sclerosing agents | ||
| + | * absolute etoh, | ||
| + | * bleomycin, doxycycline foam (albumin+air) | ||
| + | * sodium tetradecyl sulfate (with gel foam) | ||
| + | * Strategies | ||
| + | * dual agent therapies for macrocysts | ||
| + | * foam for microcysts | ||
| + | * Complications | ||
| + | * diplopia, corneal exposure, mydriasis! increased IOP, orbital compartment syndrome, corneal/ | ||
| + | * Shortcomings of sclerosing treatment | ||
| + | * won't affect fibrous component | ||
| + | * multiple treatments often needed | ||